1. Sahin, S, Karadeniz, A. Nonalcoholic fatty pancreas disease is associated with subclinical atherosclerosis. Angiology. 2021, Accepted for publication.
Google Scholar | SAGE Journals2. Katsiki, N, Athyros, VG, Mikhailidis, DP. Abnormal peri-organ or intra-organ fat (APIFat) deposition: an underestimated predictor of vascular risk?. Curr Vasc Pharmacol. 2016;14:432-441.
Google Scholar | Crossref | Medline3. Katsiki, N, Mikhailidis, DP. Perivascular adipose tissue: Pathophysiological links with inflammation, atherosclerosis, and thrombosis. Angiology. 2021:33197211014676. doi: 10.1177/00033197211014676. Epub ahead of print.
Google Scholar | SAGE Journals4. Katsiki, N, Mikhailidis, DP. Epicardial fat: a novel marker of subclinical atherosclerosis in clinical practice? Anatol J Cardiol. 2017;17:64-65.
Google Scholar | Medline5. Wong, WK, Chan, WK. Nonalcoholic fatty liver disease: a global perspective. Clin Therapeut. 2021;43:473-499.
Google Scholar | Crossref | Medline6. Yayla, Ç, Yayla, KG, Karanfil, M, et al. The nonalcoholic fatty liver disease and cardiovascular diseases. Angiology. 2020;71:87.
Google Scholar | SAGE Journals7. Turan, Y . The nonalcoholic fatty liver disease fibrosis score is related to epicardial fat thickness and complexity of coronary artery disease. Angiology. 2020;71:77-82.
Google Scholar | SAGE Journals | ISI8. Muzurović, E, Mikhailidis, DP, Mantzoros, C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metab Clin Exp. 2021;119:154770.
Google Scholar | Crossref | Medline9. Dite, P, Blaho, M, Bojkova, M, Jabandziev, P, Kunovsky, L. Nonalcoholic fatty pancreas disease: Clinical consequences. Dig Dis. 2020;38:143-149.
Google Scholar | Crossref | Medline10. Filippatos, TD, Alexakis, K, Mavrikaki, V, Mikhailidis, DP. Nonalcoholic fatty pancreas disease: Role in metabolic syndrome, “prediabetes,” diabetes and atherosclerosis [Online ahead of print]. Dig Dis Sci. 2021. DOI: 10.1007/s10620-021-06824-7
Google Scholar | Crossref | Medline11. van Geenen, EM, Smits, MM, Schreuder, T, van der Peet, DL, Bloemena, E, Mulder, CJ. Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas. 2010;39:1185-1190.
Google Scholar | Crossref | Medline12. Rosenblatt, R, Mehta, A, Snell, D, Hissong, E, Kierans, AS, Kumar, S. Ultrasonographic nonalcoholic fatty pancreas is associated with advanced fibrosis in NAFLD: A retrospective analysis. Dig Dis Sci. 2019;64:262–268.
Google Scholar | Crossref | Medline13. Zhou, J, Li, ML, Zhang, DD, et al. The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population. Pancreatology. 2016;16:578-583.
Google Scholar | Crossref | Medline14. Lee, EH, Kim, JY, Yang, HR. Ectopic pancreatic fat as a risk factor for hypertension in children and adolescents with nonalcoholic fatty liver disease. J Clin Hypertens. 2021;23:1506-1515.
Google Scholar | Crossref15. Uygun, A, Kadayifci, A, Demirci, H, et al. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. Eur J Intern Med. 2015;26:37-41.
Google Scholar | Crossref | Medline16. Ozturk, K, Dogan, T, Celikkanat, S, et al. The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2018;30:411-417.
Google Scholar | Crossref | Medline17. Kul, S, Karadeniz, A, Dursun, İ, et al. Non-alcoholic fatty pancreas disease is associated with increased epicardial adipose tissue and aortic intima-media thickness. Acta Cardiol Sin. 2019;35:118-125.
Google Scholar | Medline18. Takahashi, M, Hori, M, Ishigamori, R, Mutoh, M, Imai, T, Nakagama, H. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans. Cancer Sci. 2018;109:3013-3023.
Google Scholar | Crossref | Medline